These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26971081)

  • 1. Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.
    Rhein J; Morawski BM; Hullsiek KH; Nabeta HW; Kiggundu R; Tugume L; Musubire A; Akampurira A; Smith KD; Alhadab A; Williams DA; Abassi M; Bahr NC; Velamakanni SS; Fisher J; Nielsen K; Meya DB; Boulware DR;
    Lancet Infect Dis; 2016 Jul; 16(7):809-818. PubMed ID: 26971081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.
    Rhein J; Huppler Hullsiek K; Tugume L; Nuwagira E; Mpoza E; Evans EE; Kiggundu R; Pastick KA; Ssebambulidde K; Akampurira A; Williams DA; Bangdiwala AS; Abassi M; Musubire AK; Nicol MR; Muzoora C; Meya DB; Boulware DR;
    Lancet Infect Dis; 2019 Aug; 19(8):843-851. PubMed ID: 31345462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
    Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
    Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive sertraline for asymptomatic cryptococcal antigenemia: A randomized clinical trial.
    Boulware DR; Nalintya E; Rajasingham R; Kirumira P; Naluyima R; Turya F; Namanda S; Rutakingirwa MK; Skipper CP; Nikweri Y; Hullsiek KH; Bangdiwala AS; Meya DB
    Med Mycol; 2020 Nov; 58(8):1037-1043. PubMed ID: 32415846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis.
    Alhadab AA; Rhein J; Tugume L; Musubire A; Williams DA; Abassi M; Nicol MR; Meya DB; Boulware DR; Brundage RC;
    J Pharmacokinet Pharmacodyn; 2019 Dec; 46(6):565-576. PubMed ID: 31584146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
    Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G;
    N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.
    Jarvis JN; Meintjes G; Rebe K; Williams GN; Bicanic T; Williams A; Schutz C; Bekker LG; Wood R; Harrison TS
    AIDS; 2012 Jun; 26(9):1105-13. PubMed ID: 22421244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
    Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
    Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience.
    Villanueva-Lozano H; Treviño-Rangel RJ; González GM; Hernández-Rodríguez PA; Camacho-Ortiz A; Castillo-Reyna L; Galindo-Alvarado SG; Martínez-Reséndez MF
    Infection; 2018 Feb; 46(1):25-30. PubMed ID: 28815430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
    Bisson GP; Molefi M; Bellamy S; Thakur R; Steenhoff A; Tamuhla N; Rantleru T; Tsimako I; Gluckman S; Ravimohan S; Weissman D; Tebas P
    Clin Infect Dis; 2013 Apr; 56(8):1165-73. PubMed ID: 23362285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis.
    Loyse A; Wilson D; Meintjes G; Jarvis JN; Bicanic T; Bishop L; Rebe K; Williams A; Jaffar S; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2012 Jan; 54(1):121-8. PubMed ID: 22052885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
    Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
    Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple Etiologies.
    Bahr NC; Skipper CP; Huppler-Hullsiek K; Ssebambulidde K; Morawski BM; Engen NW; Nuwagira E; Quinn CM; Ramachandran PS; Evans EE; Lofgren SM; Abassi M; Muzoora C; Wilson MR; Meya DB; Rhein J; Boulware DR
    Clin Infect Dis; 2023 Mar; 76(6):1080-1087. PubMed ID: 36303432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report.
    Otto SBJ; George PE; Mercedes R; Nabukeera-Barungi N
    BMC Infect Dis; 2020 Jan; 20(1):68. PubMed ID: 31964348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic relapse of HIV-associated cryptococcal meningitis: recurrent cryptococcal meningitis or Cryptococcus-related immune reconstitution inflammatory syndrome?
    Jhamb R; Kashyap B; Das S; Berry N; Garg A
    Int J STD AIDS; 2014 Apr; 25(5):369-72. PubMed ID: 24108453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.
    Mfinanga S; Chanda D; Kivuyo SL; Guinness L; Bottomley C; Simms V; Chijoka C; Masasi A; Kimaro G; Ngowi B; Kahwa A; Mwaba P; Harrison TS; Egwaga S; Jaffar S;
    Lancet; 2015 May; 385(9983):2173-82. PubMed ID: 25765698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.